title: Effects of mechanochemically activated doxorubicin and 40 MHz frequency irradiation on human A-549 lung carcinoma cells.
abstract: OBJECTIVE
  To study in vitro influence of mechanochemically activated (MA) doxorubicin (DOXO) and electromagnetic irradiation (EMI) on human lung carcinoma A-549 cells.
  
  
  METHODS
  Solid state DOXO was MA by input energy 20 W/g during 5 min. Tumor cells were exposed to 40 MHz EMI with power density 2 W/cm(2) at temperature 37 degrees C.
  
  
  RESULTS
  Particles of MA DOXO have sizes 10 time smaller than officinal DOXO, high performance liquid chromatography analysis showed that parameters of officinal and MA DOXO were quantitatively equal. Mechanochemical activation initiated in the drug formation of free radicals with g = 2.005, g = 2.003 and g = 1.97. LD(50) values of MA DOXO were 5 times lower than that of officinal drug. Cell survival decreased in the following way after effects EMI --> officinal DOXO --> MA DOXO --> officinal DOXO + EMI --> MA DOXO + EMI.
  
  
  CONCLUSIONS
  Treatment by MA DOXO and drug with EMI at 37 degrees C showed better targeting of drug in human lung carcinoma A-549 cells outcomes than officinal DOXO.
authors.affiliation: Institute of Oncology, Academy of Medical Sciences of Ukraine, Kyiv, Ukraine. orel@ucr.kiev.ua
authors.forename: V E
authors.initials: VE
authors.lastname: Orel
authors.forename: Yu I
authors.initials: YI
authors.lastname: Kudryavets
authors.forename: S
authors.initials: S
authors.lastname: Satz
authors.forename: N A
authors.initials: NA
authors.lastname: Bezdenezhnih
authors.forename: M I
authors.initials: MI
authors.lastname: Danko
authors.forename: N N
authors.initials: NN
authors.lastname: Khranovskaya
authors.forename: A V
authors.initials: AV
authors.lastname: Romanov
authors.forename: N N
authors.initials: NN
authors.lastname: Dzyatkovskaya
authors.forename: A P
authors.initials: AP
authors.lastname: Burlaka
authors.forename: E P
authors.initials: EP
authors.lastname: Sidorik
mesh_terms: D000903:Antibiotics, Antineoplastic / Q000493:pharmacokinetics* / Q000494:pharmacology*; D002277:Carcinoma / Q000473:pathology*; D004317:Doxorubicin / Q000493:pharmacokinetics* / Q000494:pharmacology*; D016503:Drug Delivery Systems; D004574:Electromagnetic Fields; D017276:Friction; D006801:Humans; D008175:Lung Neoplasms / Q000473:pathology*; D010316:Particle Size; D013696:Temperature; D014407:Tumor Cells, Cultured
chemical_list: D000903:Antibiotics, Antineoplastic; D004317:Doxorubicin